Aclipse Therapeutics to Collaborate with Mayo Clinic on Phase 2 Clinical Development of M107 for the Treatment of Gastroparesis

Aclipse Therapeutics LLC ("Aclipse" or "the Company") today announced that it has entered into a clinical collaboration and ...
Post Bulletin

How is Mayo Clinic financing its 'Bold' future?

Meanwhile, Unbound is mostly money being spent by Mayo Clinic, with some coming from donors who are helping fund some of Mayo ...

Enduring principles: How a 19th-century vision still shapes Mayo Clinic’s modern achievements

Their foundational principle—the needs of the patient come first—has guided the institution since its earliest days and ...
Mayo Clinic

Research Experiences for Teachers Program

Mayo Clinic's Research Experiences for Teachers Program consists of a number of unique components and features.
Becker's Hospital Review

How Mayo Clinic is scaling its expertise globally

Mayo Clinic’s data platform is redefining how fast care can evolve — and how far high-quality care can reach. The Rochester, Minn.-based health system launched Mayo Clinic Platform in 2019 to extend ...

Alzheimer’s could be predicted years before symptoms arise using new risk tool

Mayo Clinic scientists have developed a new method to predict Alzheimer's risk decades before symptoms appear, using brain scans and genetics to estimate a 10-year likelihood.
South Florida Reporter

New Mayo Clinic Tool Predicts Alzheimer’s Risk Years Before Symptoms Begin

Mayo Clinic researchers have developed a new tool that can estimate a person’s risk of developing memory and thinking ...